Standout Papers

Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI)... 2010 2026 2015 2020 734
  1. Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer (2010)
    Marc Peeters, Timothy Price et al. Journal of Clinical Oncology

Immediate Impact

4 from Science/Nature 84 standout
Sub-graph 1 of 18

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
A gut microbial signature for combination immune checkpoint blockade across cancer types
2024 Standout
1 intermediate paper

Works of Andrew Strickland being referenced

Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial
2021
Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial
2010

Author Peers

Author Last Decade Papers Cites
Andrew Strickland 867 423 206 271 31 1.0k
Roger Sidhu 703 378 154 246 29 885
Federico Nasroulah 809 389 150 152 28 969
Vicente Alonso-Orduña 809 392 141 136 23 981
Clemens Gießen 933 542 251 267 46 1.1k
M. E. Vega-Villegas 931 542 269 177 17 1.2k
Regina Esser 899 463 191 334 39 1.1k
Alan Rong 825 366 156 262 26 1.0k
Claus-Christoph Steffens 946 467 131 161 18 1.1k
Swantje Held 877 422 225 310 81 1.1k
B. Barón 634 529 353 272 28 1.4k

All Works

Loading papers...

Rankless by CCL
2026